|
KIAA2026 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.57089999996973E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.578400E-04 |
| Normal-vs-Stage2 |
9.775700E-03 |
| Normal-vs-Stage3 |
1.08529962794535E-10 |
| Normal-vs-Stage4 |
1.40290001837684E-09 |
| Stage1-vs-Stage2 |
7.217400E-01 |
| Stage1-vs-Stage3 |
8.06870000000792E-05 |
| Stage1-vs-Stage4 |
1.242420E-04 |
| Stage2-vs-Stage3 |
5.271700E-02 |
| Stage2-vs-Stage4 |
3.256000E-02 |
| Stage3-vs-Stage4 |
6.262400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.43350000045584E-07 |
| Normal-vs-AfricanAmerican |
4.604100E-03 |
| Normal-vs-Asian |
6.130400E-01 |
| Caucasian-vs-AfricanAmerican |
7.308400E-01 |
| Caucasian-vs-Asian |
1.627040E-01 |
| AfricanAmerican-vs-Asian |
7.133700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.20940000014613E-07 |
| Normal-vs-Female |
1.519270E-03 |
| Male-vs-Female |
3.301800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.671700E-02 |
| Normal-vs-Age(41-60Yrs) |
4.433900E-04 |
| Normal-vs-Age(61-80Yrs) |
2.89379997742145E-09 |
| Normal-vs-Age(81-100Yrs) |
1.241090E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.596000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.395000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.785400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.035200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.079250E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.598200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.172000E-01 |
| Normal-vs-Grade 2 |
4.778100E-03 |
| Normal-vs-Grade 3 |
3.89330001571153E-09 |
| Normal-vs-Grade 4 |
9.78980008170538E-10 |
| Grade 1-vs-Grade 2 |
3.682100E-02 |
| Grade 1-vs-Grade 3 |
2.231600E-04 |
| Grade 1-vs-Grade 4 |
3.80100000000327E-05 |
| Grade 2-vs-Grade 3 |
2.162300E-04 |
| Grade 2-vs-Grade 4 |
7.80460000000538E-05 |
| Grade 3-vs-Grade 4 |
1.398600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.178110E-03 |
| Normal-vs-ccB subtype |
3.95699999999888E-05 |
| ccA subtype-vs-ccB subtype |
7.994200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.801140E-04 |
| Normal-vs-N1 |
2.163900E-04 |
| N0-vs-N1 |
1.165020E-01 |
|
|
